You are here: Industry Insights > CoronaVac

News List

China grants conditional approval to 2nd COVID-19 vaccine expresspharma
February 07, 2021
China has granted conditional approval for its second COVID-19 vaccine, ahead of the expected emergency approval from the WHO for two of its jabs that would enable the country to step-up global supplies of the shots.
16 Chinese COVID-19 vaccines undergoing clinical trials: Official expresspharma
February 02, 2021
China is conducting clinical trials of 16 COVID-19 vaccines, seven of which have entered phase-III trials and one has conditionally hit the market, said Wu Yuanbin, an official with the Ministry of Science and Technology, informed state-run CGTN TV.
Sinovac get $515 mn funding for COVID-19 vaccine production expresspharma
December 08, 2020
Sinovac said that it would be able to manufacture 300 million vaccine doses annually and aims to complete construction of a second production facility by the end of 2020 to increase annual COVID-19 vaccine production capacity to 600 million doses.
Chinese vaccine candidate based on inactivated SARS-CoV-2 virus appears safe and induces an immune response in healthy volunteers worldpharmanews
November 20, 2020
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published in The Lancet Infectious Diseases journal, finding the formulation appears safe and induces ...
Sinovac’s CoronaVac triggers quick immune response in Covid-19 trial pharmaceutical-technology
November 19, 2020
Sinovac Biotech has reported the preliminary results from Phase I/II trial that showed its experimental Covid-19 vaccine, CoronaVac, triggered a quick immune response in healthy adults.
CoronaVac from Sinovac triggers quick immune response expresspharma
November 19, 2020
The Sinovac findings came from results in Phase I and Phase II clinical trials in China involving over 700 participants.
SinoVac gets authorisation to restart Covid-19 vaccine trial in Brazil pharmaceutical-technology
November 12, 2020
Chinese biopharmaceutical firm Sinovac is set to resume the Phase III trial of the Inactivated Covid-19 vaccine, CoronaVaC, after the Brazil National Health Surveillance Agency (Anvisa) authorised its resumption.
Sinovac begins Covid-19 vaccine candidate trials in Turkey pharmaceutical-business-review
September 27, 2020
Chinese biopharmaceutical company Sinovac Biotech has begun phase III clinical trials for its inactivated Covid-19 vaccine candidate in Turkey.
Sinovac reports preliminary Phase I/II results of COVID-19 vaccine in elderly volunteers worldpharmanews
September 24, 2020
Sinovac Biotech Ltd. ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences (Sinovac LS), or "CoronaVac,"shows good safety ...
Sinovac’s COVID-19 vaccine candidate get emergency use approval in China expresspharma
August 31, 2020
Sinovac Biotech’s coronavirus vaccine candidate CoronaVac was approved for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a person familiar with the matter said.

Previous page 1 2 3 Next page